Sign In

Matthew Webb

Global Lead, Vyndaqel at Pfizer

Matthew Francis Webb is the Global Lead for Vyndaqel at Pfizer.1 Based on his LinkedIn profile, he has the following background:

  • Current role: Global Lead for Vyndaqel at Pfizer
  • Education: Attended Imperial College London
  • Location: United Kingdom
  • Connections: Over 500 connections on LinkedIn

Vyndaqel (tafamidis) is a medication developed by Pfizer for treating rare diseases, specifically transthyretin amyloid cardiomyopathy.2 As the Global Lead for this product, Matthew Webb likely plays a key role in its global strategy and commercialization efforts.

While his specific responsibilities are not detailed in the available information, a global lead position typically involves overseeing the product's performance across different markets, developing strategic plans, and collaborating with various teams to drive the medication's success worldwide.

Highlights

Port Charlotte sun ( 2023-07-02 ) - University of Florida
Port Charlotte sun ( 2023-07-02 ) - University of Florida
[PDF] HIGHLANDS NEWS-SUN - University of Florida

Related Questions

What is Matthew Francis Webb's background before joining Pfizer?
What is Vyndaqel used for?
How long has Matthew Francis Webb been with Pfizer?
What are Matthew Francis Webb's main responsibilities as Global Lead of Vyndaqel?
What other roles has Matthew Francis Webb held in the pharmaceutical industry?
Matthew Webb
Matthew Webb, photo 1
Matthew Webb, photo 2
Add to my network

Location

United Kingdom